arrow
E

Edward A. Fisher

nyu langone health
H指数:118
被引数:6.2万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Gene regulatory network analysis identifies auranofin as an anti-atherosclerotic drug

基因调控网络分析确定auranofin为一种抗动脉粥样硬化药物

2026-09-020
OA
Platelets impair the resolution of inflammation in atherosclerotic plaques in insulin-resistant mice after lipid lowering

血小板在降脂治疗后损害胰岛素抵抗小鼠动脉粥样硬化斑块中炎症的消退。

2025-11-100
OA
Caloric restriction promotes resolution of atherosclerosis in obese mice, while weight regain accelerates its progression

热量限制促进肥胖小鼠动脉粥样硬化的消退,而体重反弹则加速其进展。

2025-09-162
OA
Type I IFN induces long-chain acyl-CoA synthetase 1 to generate a phosphatidic acid reservoir for lipotoxic saturated fatty acids
2025-01-010
OAAI
FITM2 deficiency results in ER lipid accumulation, ER stress, and reduced apolipoprotein B lipidation and VLDL triglyceride secretion in vitro and in mouse liver
2024-12-010
OAAI
Immune checkpoint landscape of human atherosclerosis and influence of cardiometabolic factors
2024-11-291
OAAI
The Role of Oxidized Phospholipids in Triggering Trained Immunity and Accelerating Atherosclerotic Plaque Inflammation during Cholesterol Cycling

氧化磷脂在触发训练性免疫和加速胆固醇循环期间动脉粥样硬化斑块炎症中的作用

2024-11-120
PRE
The immune checkpoint landscape in human atherosclerosis: influence of lipid lowering and type 2 diabetes

人类动脉粥样硬化中的免疫检查点景观:降脂治疗和2型糖尿病的影响

2024-11-120
PRE